SpheroTec GmbH
Martinsried, Bayern, Germany
About SpheroTec GmbH
Spherotec is a biotech company using 3D cell-culture systems that have similar properties to microtumors in cancer patients. On this basis, Spherotec offers pharmaceutical and biotech companies the opportunity to conduct functional tests of drug candidates for oncology in close to real conditions. This permits the early identification of promising substances and gives a broad profile of the effects of substances. The process also allows the definition of the kinds of tumors for which a substance or a combination of substances has the best clinical efficacy
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $52.6K
- Last round: Grant (Jan 2017)
- Website: spherotec.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/spherotec-gmbh-2252708 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.